Biogen's Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy Life Science Investing
Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society 68th Annual Scientific Meeting Life Science Investing
LUPKYNIS Associated with a Statistically Significant 53% Reduction in Risk of Renal-Related Event or Death Life Science Investing
BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value Life Science Investing
EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus Life Science Investing
PRINCIPAL TECHNOLOGIES ANNOUNCES PRIVATE PLACEMENT FINANCING AND DEBT SETTLEMENT TRANSACTIONS Technology Investing
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 31, 2026 Life Science Investing
